Discovery of Topoisomerase I Inhibitor Nitidine Derivatives with IL-10 Enhancing Activity for the Treatment of Sepsis

Bibliographic Details
Main Authors: Siyu Liu, Yanting Pang, Zeng Zhao, Qingyan Sun
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2024-03-01
Series:Pharmaceutical Fronts
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1780496
_version_ 1797260564345389056
author Siyu Liu
Yanting Pang
Zeng Zhao
Qingyan Sun
author_facet Siyu Liu
Yanting Pang
Zeng Zhao
Qingyan Sun
author_sort Siyu Liu
collection DOAJ
first_indexed 2024-04-24T23:27:20Z
format Article
id doaj.art-9ed36a6918004cc180c2b24fb9bd2569
institution Directory Open Access Journal
issn 2628-5088
2628-5096
language English
last_indexed 2024-04-24T23:27:20Z
publishDate 2024-03-01
publisher Georg Thieme Verlag KG
record_format Article
series Pharmaceutical Fronts
spelling doaj.art-9ed36a6918004cc180c2b24fb9bd25692024-03-15T23:47:54ZengGeorg Thieme Verlag KGPharmaceutical Fronts2628-50882628-50962024-03-010601e47e6110.1055/s-0044-1780496Discovery of Topoisomerase I Inhibitor Nitidine Derivatives with IL-10 Enhancing Activity for the Treatment of SepsisSiyu Liu0Yanting Pang1Zeng Zhao2Qingyan Sun3National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co. Ltd., China State Institute of Pharmaceutical Industry Co. Ltd., Shanghai, People's Republic of ChinaNational Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co. Ltd., China State Institute of Pharmaceutical Industry Co. Ltd., Shanghai, People's Republic of ChinaNational Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co. Ltd., China State Institute of Pharmaceutical Industry Co. Ltd., Shanghai, People's Republic of ChinaNational Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co. Ltd., China State Institute of Pharmaceutical Industry Co. Ltd., Shanghai, People's Republic of Chinahttp://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1780496Nitidine Chlorideinterleukin-10structural modificationsepsis
spellingShingle Siyu Liu
Yanting Pang
Zeng Zhao
Qingyan Sun
Discovery of Topoisomerase I Inhibitor Nitidine Derivatives with IL-10 Enhancing Activity for the Treatment of Sepsis
Pharmaceutical Fronts
Nitidine Chloride
interleukin-10
structural modification
sepsis
title Discovery of Topoisomerase I Inhibitor Nitidine Derivatives with IL-10 Enhancing Activity for the Treatment of Sepsis
title_full Discovery of Topoisomerase I Inhibitor Nitidine Derivatives with IL-10 Enhancing Activity for the Treatment of Sepsis
title_fullStr Discovery of Topoisomerase I Inhibitor Nitidine Derivatives with IL-10 Enhancing Activity for the Treatment of Sepsis
title_full_unstemmed Discovery of Topoisomerase I Inhibitor Nitidine Derivatives with IL-10 Enhancing Activity for the Treatment of Sepsis
title_short Discovery of Topoisomerase I Inhibitor Nitidine Derivatives with IL-10 Enhancing Activity for the Treatment of Sepsis
title_sort discovery of topoisomerase i inhibitor nitidine derivatives with il 10 enhancing activity for the treatment of sepsis
topic Nitidine Chloride
interleukin-10
structural modification
sepsis
url http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1780496
work_keys_str_mv AT siyuliu discoveryoftopoisomeraseiinhibitornitidinederivativeswithil10enhancingactivityforthetreatmentofsepsis
AT yantingpang discoveryoftopoisomeraseiinhibitornitidinederivativeswithil10enhancingactivityforthetreatmentofsepsis
AT zengzhao discoveryoftopoisomeraseiinhibitornitidinederivativeswithil10enhancingactivityforthetreatmentofsepsis
AT qingyansun discoveryoftopoisomeraseiinhibitornitidinederivativeswithil10enhancingactivityforthetreatmentofsepsis